Thomas F. Westbrook

14.4k total citations · 4 hit papers
41 papers, 5.9k citations indexed

About

Thomas F. Westbrook is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Thomas F. Westbrook has authored 41 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 10 papers in Oncology and 8 papers in Cell Biology. Recurrent topics in Thomas F. Westbrook's work include Epigenetics and DNA Methylation (8 papers), RNA modifications and cancer (7 papers) and Cancer-related gene regulation (6 papers). Thomas F. Westbrook is often cited by papers focused on Epigenetics and DNA Methylation (8 papers), RNA modifications and cancer (7 papers) and Cancer-related gene regulation (6 papers). Thomas F. Westbrook collaborates with scholars based in United States, Canada and China. Thomas F. Westbrook's co-authors include Stephen J. Elledge, Michael R. Schlabach, Ji Luo, Kwok‐Kin Wong, Chad J. Creighton, Danan Li, Michael J. Emanuele, Don X. Nguyen, Anthony C. Liang and Mamie Z. Li and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Thomas F. Westbrook

40 papers receiving 5.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Energy-stress-mediated AMPK activation inhibits ferroptosis

2020 851 citations Hyemin Lee, Fereshteh Zandkarimi et al. Nature Cell Biology profile →
A Genome-wide RNAi Screen Identifies Multiple Synthetic Lethal Interactions with the Ras Oncogene

2009 779 citations Ji Luo, Michael J. Emanuele et al. Cell profile →
A resource for large-scale RNA-interference-based screens in mammals

2004 554 citations Mamie Z. Li, Kenneth Chang et al. Nature Cell Biology profile →
The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo

2011 473 citations Guang Hu, Mamie Z. Li et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas F. Westbrook United States	28	4.4k	1.5k	1.4k	906	541	41	5.9k
Marie Classon United States	27	4.4k 1.0×	1.1k 0.7×	2.1k 1.5×	726 0.8×	430 0.8×	43	5.9k
Min Sup Song United States	25	4.2k 1.0×	1.5k 1.0×	1.1k 0.8×	444 0.5×	273 0.5×	53	5.3k
Edgar Dahl Germany	55	5.5k 1.3×	1.1k 0.7×	1.7k 1.2×	651 0.7×	642 1.2×	158	7.9k
Dung‐Fang Lee United States	36	4.9k 1.1×	1.4k 0.9×	1.6k 1.1×	391 0.4×	368 0.7×	87	6.3k
Shiaw‐Yih Lin United States	36	4.8k 1.1×	1.1k 0.7×	2.4k 1.7×	525 0.6×	589 1.1×	78	6.3k
Lloyd C. Trotman United States	26	5.2k 1.2×	1.1k 0.7×	1.4k 1.0×	813 0.9×	591 1.1×	44	6.4k
Enhua Wang China	37	4.4k 1.0×	1.3k 0.9×	1.8k 1.3×	1.0k 1.1×	242 0.4×	317	6.6k
Shuichi Tsutsumi Japan	43	4.4k 1.0×	1.2k 0.8×	773 0.6×	520 0.6×	606 1.1×	83	5.8k
Johannes H. Schulte Germany	42	4.3k 1.0×	2.1k 1.4×	1.3k 0.9×	368 0.4×	437 0.8×	176	6.3k
Antonino Passaniti United States	39	3.6k 0.8×	1.5k 1.0×	1.1k 0.8×	549 0.6×	437 0.8×	85	5.6k

Countries citing papers authored by Thomas F. Westbrook

Since Specialization

Citations

This map shows the geographic impact of Thomas F. Westbrook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas F. Westbrook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas F. Westbrook more than expected).

Fields of papers citing papers by Thomas F. Westbrook

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas F. Westbrook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas F. Westbrook. The network helps show where Thomas F. Westbrook may publish in the future.

Co-authorship network of co-authors of Thomas F. Westbrook

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas F. Westbrook. A scholar is included among the top collaborators of Thomas F. Westbrook based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas F. Westbrook. Thomas F. Westbrook is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cai, Wesley L., Huacui Chen, Sarah J. Kurley, et al.. (2022). Human WDR5 promotes breast cancer growth and metastasis via KMT2-independent translation regulation. eLife. 11. 14 indexed citations

Shafaee, Maryam Nemati, et al.. (2022). Abstract OT2-28-01: A phase 2 study of sitravatinib in metastatic, pre-treated, triple negative breast cancer, NCT # 04123704. Cancer Research. 82(4_Supplement). OT2–28. 1 indexed citations

Gao, Yang, Elena B. Kabotyanski, Jonathan H. Shepherd, et al.. (2021). Tumor Suppressor PLK2 May Serve as a Biomarker in Triple-Negative Breast Cancer for Improved Response to PLK1 Therapeutics. Cancer Research Communications. 1(3). 178–193. 8 indexed citations

Lee, Hyemin, Fereshteh Zandkarimi, Yilei Zhang, et al.. (2020). Energy-stress-mediated AMPK activation inhibits ferroptosis. Nature Cell Biology. 22(2). 225–234. 851 indexed citations breakdown →

Zeid, Rhamy, Matthew A. Lawlor, Evon Poon, et al.. (2018). Enhancer invasion shapes MYCN-dependent transcriptional amplification in neuroblastoma. Nature Genetics. 50(4). 515–523. 129 indexed citations

Stylianou, Nataly, Melanie Lehman, Chenwei Wang, et al.. (2018). A molecular portrait of epithelial–mesenchymal plasticity in prostate cancer associated with clinical outcome. Oncogene. 38(7). 913–934. 79 indexed citations

Dasgupta, Subhamoy, Kimal Rajapakshe, Bokai Zhu, et al.. (2018). Metabolic enzyme PFKFB4 activates transcriptional coactivator SRC-3 to drive breast cancer. Nature. 556(7700). 249–254. 185 indexed citations

Wang, Jarey H., Anna Guzman, Sean M. Cullen, et al.. (2017). Loss of De Novo DNA Methyltransferase DNMT3A Impacts Alternative Splicing in Hematopoietic Stem Cells. Blood. 130. 1–1. 11 indexed citations

Rousseaux, Maxime W.C., María de Haro, Cristian A. Lasagna‐Reeves, et al.. (2016). TRIM28 regulates the nuclear accumulation and toxicity of both alpha-synuclein and tau. eLife. 5. 81 indexed citations

10.

Wang, Hai, C. Ron Yu, Xia Gao, et al.. (2015). The Osteogenic Niche Promotes Early-Stage Bone Colonization of Disseminated Breast Cancer Cells. Cancer Cell. 27(2). 193–210. 272 indexed citations

11.

Miao, Qi, Amy T. Ku, Jeffrey Howard, et al.. (2014). Tcf3 promotes cell migration and wound repair through regulation of lipocalin 2. Nature Communications. 5(1). 4088–4088. 55 indexed citations

12.

Pallasch, Christian P., Christian Braun, Michael T. Hemann, et al.. (2013). A role for PVRL4-driven cell-cell interactions in tumorigenesis. DSpace@MIT (Massachusetts Institute of Technology). 3 indexed citations

13.

Cheung, William K.C., Minghui Zhao, Zongzhi Liu, et al.. (2013). Control of Alveolar Differentiation by the Lineage Transcription Factors GATA6 and HOPX Inhibits Lung Adenocarcinoma Metastasis. Cancer Cell. 23(6). 725–738. 107 indexed citations

14.

Pei, Yanxin, Colin E. Moore, Jun Wang, et al.. (2012). An Animal Model of MYC-Driven Medulloblastoma. Cancer Cell. 21(2). 155–167. 211 indexed citations

15.

Luo, Ji, Michael J. Emanuele, Danan Li, et al.. (2009). A Genome-wide RNAi Screen Identifies Multiple Synthetic Lethal Interactions with the Ras Oncogene. Cell. 137(5). 835–848. 779 indexed citations breakdown →

16.

Schlabach, Michael R., Ji Luo, Nicole L. Solimini, et al.. (2008). Cancer Proliferation Gene Discovery Through Functional Genomics. Science. 319(5863). 620–624. 291 indexed citations

17.

Westbrook, Thomas F., Guang Hu, Xiaolu L. Ang, et al.. (2008). SCFβ-TRCP controls oncogenic transformation and neural differentiation through REST degradation. Nature. 452(7185). 370–374. 251 indexed citations

18.

Mulligan, Peter, Thomas F. Westbrook, Matthias Ottinger, et al.. (2008). CDYL Bridges REST and Histone Methyltransferases for Gene Repression and Suppression of Cellular Transformation. Molecular Cell. 32(5). 718–726. 122 indexed citations

19.

Nguyen, Don X., Thomas F. Westbrook, & Dennis J. McCance. (2002). Human Papillomavirus Type 16 E7 Maintains Elevated Levels of the cdc25A Tyrosine Phosphatase during Deregulation of Cell Cycle Arrest. Journal of Virology. 76(2). 619–632. 67 indexed citations

20.

Westbrook, Thomas F., et al.. (1991). Aeroelastic applications of the Connection Machine. Concurrency Practice and Experience. 3(6). 715–724. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact